A Mobile Health Intervention to Reduce Diabetes Disparities in Chinese Americans
2 other identifiers
interventional
60
1 country
1
Brief Summary
Chinese Americans are one of the fastest growing immigrant groups in the US, who suffer disproportionately high type 2 diabetes (T2D) burden and have poorly controlled T2D. Despite the well-documented T2D disparities in this minority group, limited work has been conducted to improve health outcomes in Chinese Americans. The goal of this Pathway to Independence Award (K99/R00) is to expedite the candidate's transition to an independent investigator who possesses focused expertise in development and evaluation of culturally and linguistically tailored and sustainable interventions to reduce T2D disparities in Chinese Americans. In the K99 phase of this award, the candidate will obtain critical training needed to accomplish this goal and will develop a short message service (SMS) intervention to improve T2D management in Chinese Americans. More specifically, the aims are to 1) characterize barriers and facilitators of glycemic control in Chinese Americans with T2D (Aim 1a); 2) develop culturally and linguistically tailored SMS intervention content (Aim 1b); and 3) assess the feasibility and acceptability of the SMS intervention in a pre-, post-test study (Aim 1c). In the R00 phase, the candidate will refine the SMS intervention based on the K99 pilot data and evaluate the proof-of-concept regarding its efficacy in a pilot randomized controlled trial among 66 Chinese Americans with T2D (Aim 2). Participants will be randomized to one of 2 arms (n=30 each): 1) wait-list control and 2) SMS intervention. Both groups will continue to receive standard of care treatment for their T2D. The SMS group will receive brief lifestyle counseling videos via SMS links. At the end of the study, the wait-list control group will be provided the opportunity to receive the SMS-based counseling videos. Measurements will be obtained at baseline, 3, and 6 months. The primary outcome is HbA1c and secondary outcomes include self-efficacy, diabetes self-management behaviors, dietary intake and physical activity behaviors. Linear mixed modeling will be used to examine the group and group by time interaction effects between the SMS intervention and wait-list control group. Findings from this R00 study will inform a larger full-scale R01 efficacy trial of the SMS intervention, and ultimately, establish the candidate's program of research focused on developing and testing sustainable interventions to reduce disparities in chronic disease outcomes in Chinese Americans. This project can serve as a program model for other chronic disease interventions in Chinese Americans that require lifestyle modification (e.g., prediabetes, hypertension), or for disparities research in other high-risk immigrant populations (e.g., South Asians, Hispanic Americans).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 4, 2018
CompletedFirst Posted
Study publicly available on registry
June 15, 2018
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 21, 2023
CompletedResults Posted
Study results publicly available
December 27, 2024
CompletedFebruary 19, 2025
January 1, 2025
2.1 years
June 4, 2018
November 20, 2024
January 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Average Plasma Glucose Concentration Measured by Hemoglobin A1c (HbA1c) Levels
HbA1c testing results abstracted from medical record.
Baseline, Month 3
Change in Average Plasma Glucose Concentration Measured by Hemoglobin A1c (HbA1c) Levels
HbA1c testing results abstracted from medical record.
Baseline, Month 6
Secondary Outcomes (32)
Change in Stanford Diabetes Self-Efficacy Scale Score
Baseline, Month 3
Change in Stanford Diabetes Self-Efficacy Scale Score
Baseline, Month 6
Change in Summary of Diabetes Self-Care Activities (SDSCA) - General Diet Score
Baseline, Month 3
Change in Summary of Diabetes Self-Care Activities (SDSCA) - General Diet Score
Baseline, Month 6
Change in Summary of Diabetes Self-Care Activities (SDSCA) - Specific Diet Score
Baseline, Month 3
- +27 more secondary outcomes
Study Arms (2)
wait-list control
ACTIVE COMPARATOR3 measurement visits, baseline, 3, and 6 months
SMS intervention
ACTIVE COMPARATOR3 measurement visits, baseline, 3, and 6 months
Interventions
At the end of the study the control group will be provided with the opportunity to receive counseling videos delivered via SMS
Participants in the intervention group will receive SMS based video counseling which include both educational and SCT=-based behavioral content. In addition, participants will receive biweekly phone calls from study community health workers to review the video content and clarify questions, set goals, and problem-solve barriers to achieving the goals.
Eligibility Criteria
You may qualify if:
- self-identify as Chinese Immigrant or Chinese American
- be able to speak and understand Mandarin
- self-report a diagnosis of T2D
- baseline HbA1c ≥ 7%
- be currently using WeChat or text messages• be willing to receive WeChat or text messages regarding T2D management
- express strong interest and confidence in finishing watching 2 diabetes videos each week for a total of 12 weeks
- express motivation to make lifestyle changes to control their diabetes
- be willing to wear ActiGraph for 8 days
You may not qualify if:
- unable or unwilling to provide informed consent
- unable to participate meaningfully in the intervention (e.g., uncorrected sight and hearing impairment)
- unwilling to accept randomization assignment
- pregnant, plans to becomes pregnant in the next 6 months, or who become pregnant during the study
- breastfeeding
- live in a facility or other health care setting where they have to control over diabetes self-management
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NYU Langone Health
New York, New York, 10016, United States
Related Publications (3)
Liu J, Cao J, Shi Y, Sevick MA, Islam N, Feldman N, Li H, Wang C, Zhao Y, Tamura K, Levy N, Jiang N, Zhu Z, Wang Y, Hong J, Hu L. A Culturally and Linguistically Tailored Intervention to Improve Diabetes-Related Outcomes in Chinese Americans With Type 2 Diabetes: Pilot Randomized Controlled Trial. JMIR Mhealth Uhealth. 2025 Oct 27;13:e78036. doi: 10.2196/78036.
PMID: 41144955DERIVEDShi Y, Sevick MA, Tang H, Wang C, Zhao Y, Yoon S, Li H, Jiang Y, Bai Y, Ong IH, Yang X, Su L, Levy N, Tamura K, Hu L. Culturally Tailored Social Media Intervention Improves Health Outcomes in Chinese Americans with Type 2 Diabetes: Preliminary Evidence from a Pilot RCT. J Gen Intern Med. 2025 Jul;40(10):2319-2329. doi: 10.1007/s11606-025-09430-9. Epub 2025 Feb 27.
PMID: 40016380DERIVEDHu L, Islam N, Zhang Y, Shi Y, Li H, Wang C, Sevick MA. Leveraging Social Media to Increase Access to an Evidence-Based Diabetes Intervention Among Low-Income Chinese Immigrants: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2022 Oct 28;11(10):e42554. doi: 10.2196/42554.
PMID: 36306161DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Lu Hu
- Organization
- NYU Langone Health
Study Officials
- PRINCIPAL INVESTIGATOR
Lu Hu, PhD
NYU Langone Health
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 4, 2018
First Posted
June 15, 2018
Study Start
March 1, 2021
Primary Completion
April 21, 2023
Study Completion
April 21, 2023
Last Updated
February 19, 2025
Results First Posted
December 27, 2024
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Access Criteria
- Requests should be directed to Lu.Hu@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).